Multiple sclerosis

Last updated: February 23, 2023

Multiple sclerosis

Med - 1ère année

Med - 1ère année

Social anxiety disorder
Panic disorder
Generalized anxiety disorder
Post-traumatic stress disorder
Serotonin and norepinephrine reuptake inhibitors
Selective serotonin reuptake inhibitors
Hyperthyroidism: Pathology review
Hyperthyroidism: Clinical
Thyroid hormones
Graves disease
Plasma anion gap
Mitosis and meiosis
Irritable bowel syndrome
Polymerase chain reaction (PCR) and reverse-transcriptase PCR (RT-PCR)
Chronic pancreatitis
Diarrhea: Clinical
Celiac disease
Ulcerative colitis
Crohn disease
Neuron action potential
Diverticulosis and diverticulitis
Gallbladder disorders: Pathology review
Pancreatitis: Pathology review
Appendicitis: Pathology review
Appendicitis
Acute cholecystitis
Pregnancy
Phobias
Obsessive-compulsive disorder
Body focused repetitive disorders
Bipolar and related disorders
Major depressive disorder
Suicide
Hashimoto thyroiditis
Alcohol use disorder
Lithium
Bone remodeling and repair
Liver anatomy and physiology
Jaundice
Neonatal jaundice: Clinical
Growth hormone and somatostatin
Lymphatic system anatomy and physiology
Puberty and Tanner staging
Precocious puberty
Delayed puberty
Turner syndrome
Constitutional growth delay
Marfan syndrome
Klinefelter syndrome
Acne vulgaris
Acute pyelonephritis
Meningitis
Varicella zoster virus
Herpes simplex virus
Pediatric infectious rashes: Clinical
Fever of unknown origin: Clinical
Measles virus
Parvovirus B19
Rubella virus
Human herpesvirus 6 (Roseola)
Kawasaki disease: Clinical
Kawasaki disease
Stevens-Johnson syndrome
Appendicitis: Clinical
Volvulus
Intussusception
Bowel obstruction: Clinical
Pediatric gastrointestinal bleeding: Clinical
Congenital gastrointestinal disorders: Pathology review
Pediatric constipation: Clinical
Intestinal atresia
Pelvic inflammatory disease
Pyloric stenosis
Hirschsprung disease
Lactose intolerance
Pediatric allergies: Clinical
Allergic rhinitis
Sinusitis
Type I hypersensitivity
Food allergy
Pediatric upper airway conditions: Clinical
Pediatric lower airway conditions: Clinical
Anaphylaxis
Asthma: Clinical
Asthma
Heart failure
Cystic fibrosis: Clinical
Respiratory system anatomy and physiology
Bacterial epiglottitis
Cystic fibrosis
Cystic fibrosis: Pathology review
Bronchiectasis
Anatomy of the cranial base
Anatomy of the cerebellum
Anatomy of the cerebral cortex
Ischemic stroke
Multiple sclerosis
Guillain-Barre syndrome
Bell palsy
Myasthenia gravis
Dermatomyositis
Polymyositis
Inclusion body myopathy
Myotonic dystrophy
Muscular dystrophy
Erb-Duchenne palsy
Ascending and descending spinal tracts
Muscle weakness: Clinical
Anatomy of the cranial meninges and dural venous sinuses
Migraine
Migraine medications
Subarachnoid hemorrhage
Anatomy and physiology of the ear
Anatomy and physiology of the eye
Seizures: Clinical
Seizures: Pathology review
Seizures and epilepsy
Anatomy of the urinary organs of the pelvis
Urinary incontinence
Urinary tract infections: Pathology review
Lower urinary tract infection
Urinary incontinence: Pathology review
Renal and urinary tract masses: Pathology review
Urinary tract infections: Clinical
Renal system anatomy and physiology
Benign prostatic hyperplasia
Abnormal uterine bleeding: Clinical
Menstrual cycle
Uterine fibroid
Osteoporosis
Osteoporosis medications
Menopause
Endometrial hyperplasia
Endometrial cancer
Citric acid cycle
Cushing syndrome and Cushing disease: Pathology review
Cushing syndrome
Dyslipidemias: Pathology review
Hypertriglyceridemia
Lipid-lowering medications: Statins
Cardiac cycle
Hypertension: Clinical
Hypertension
Blood pressure, blood flow, and resistance
Regulation of renal blood flow
Renin-angiotensin-aldosterone system
Preeclampsia & eclampsia
ECG basics
ECG intervals
ECG normal sinus rhythm
Glycogen metabolism
Gluconeogenesis
Insulin
Diabetes mellitus: Clinical
Diabetes mellitus
Glucagon
Diabetic nephropathy
Developmental dysplasia of the hip
Legg-Calve-Perthes disease
Slipped capital femoral epiphysis
Septic arthritis
Osteomyelitis
Pediatric bone and joint infections: Clinical
Pediatric bone tumors: Clinical
Gout
Antigout medications
Osteoarthritis
Meniscus tear
Coagulation (secondary hemostasis)
Role of Vitamin K in coagulation
Coagulation disorders: Pathology review
Atherosclerosis and arteriosclerosis: Pathology review
Peripheral vascular disease: Clinical
Introduction to the lymphatic system
Pneumonia: Clinical
Pneumonia
HIV (AIDS)
Endocarditis
Infective endocarditis: Clinical
Epstein-Barr virus (Infectious mononucleosis)
Plasmodium species (Malaria)
Coxiella burnetii (Q fever)
Borrelia burgdorferi (Lyme disease)
Lyme Disease
Acromegaly
Hypothyroidism
Hyperthyroidism
Adrenal insufficiency: Clinical
Hypopituitarism
Hypopituitarism: Clinical
Pituitary adenoma
Insomnia
Sleep apnea

Transcript

Watch video only

Content Reviewers

Multiple sclerosis is a demyelinating disease of the central nervous system, which includes the brain and the spinal cord.

Myelin is the protective sheath that surrounds the axons of neurons, allowing them to quickly send electrical impulses.

This myelin is produced by oligodendrocytes, which are a group of cells that support neurons.

In multiple sclerosis, demyelination happens when the immune system inappropriately attacks and destroys the myelin, which makes communication between neurons break down, ultimately leading to all sorts of sensory, motor, and cognitive problems.

Now, the brain, including the neurons in the brain, is protected by things in the blood by the blood brain barrier, which only lets certain molecules and cells through from the blood.

For immune cells like T and B cells that means having the right ligand or surface molecule to get through the blood brain barrier, this is kind of like having the a VIP pass to get into an exclusive club.

Once a T cell makes its way in it can get activated by something it encounters - in the case of multiple sclerosis, it’s activated by myelin.

Once the T-cell gets activated, it changes the blood brain barrier cells to express more receptors, and this allows immune cells to more easily bind and get in, it’s kind of like bribing the bouncer to let in a lot of people.

Now, multiple sclerosis is a type IV hypersensitivity reaction, or cell-mediated hypersensitivity. And this means that those myelin specific T-cells release cytokines like IL-1, IL-6, TNF-alpha, and interferon-gamma, and together dilate the blood vessels which allows more immune cells to get in, as well as directly cause damage to the oligodendrocytes.

The cytokines also attract B-cells and macrophages as part of the inflammatory reaction.

Those B-cells begin to make antibodies that mark the myelin sheath proteins, and then the macrophages use those antibody markers to engulf and destroy the oligodendrocytes.

Without oligodendrocytes, there’s no myelin to cover the neurons, and this leaves behind areas of scar tissue, also called plaques or sclera.

In multiple sclerosis, these immune attacks typically happen in bouts.

In other words, an autoimmune attack on the oligodendrocytes might happen, and then regulatory T cells will come in to inhibit or calm down the other immune cells, leading to a reduction in the inflammation.

Early on in multiple sclerosis, the oligodendrocytes will heal and extend out new myelin to cover the neurons, which is a process called remyelination.

Unfortunately, though, over time as the oligodendrocytes die off the remyelination stops and the damage becomes irreversible with the loss of axons.

Just like other autoimmune diseases, the exact cause of multiple sclerosis is unknown, but is linked to both genetic and environmental factors.

Genetic risk factors include being a woman and having genes that encode a specific type of immune molecule called HLA-DR2 which is used to identify and bind to foreign molecules.

Environmental risk factors might include infections as well as vitamin D deficiency, which is an interesting one because it might help explain why the rates of multiple sclerosis are higher at the northern and southern poles compared to the equator where there’s a lot more sunlight.

Together these genetic and environmental influences might lead to the body not killing off immune cells that target myelin.

So it turns out that there are four main types of multiple sclerosis based on the pattern of symptoms over time. To break this down, we can use this graph with time on the x-axis, where time refers to the lifespan of the individual, and disability on the y-axis.

The first, and by far the most common pattern of multiple sclerosis, is called relapsing-remitting multiple sclerosis or RRMS. This condition is what we just described, bouts of autoimmune attacks happening months, or even years, apart, and causing an increase in the level of disability.

For example, during a bout a person may lose some vision, but then it may be followed by improvement if there’s remyelination.

Unfortunately, though, more often than not, the remyelination process is not complete so there is often some residual disability that remains, and that means that with each attack, more and more of the central nervous system gets irreversibly damaged.

In the relapsing-remitting multiple sclerosis type there’s typically no increase in disability between bouts, so the line stays flat during that time.

Now, the second type is called secondary progressive multiple sclerosis or SPMS which initially is pretty similar to the relapse-remitting type, but over time the immune attack becomes constant which causes a steady progression of disability.

The third type is primary-progressive multiple sclerosis or PPMS, which is basically one constant attack on myelin which causes a steady progression of disability over a person’s lifetime.

The final type is progressive relapsing multiple sclerosis or PRMS, which is also one constant attack but this time there are bouts superimposed during which the disability increases even faster.

Specific symptoms varying a lot from person to person, and largely depend on the location of the plaques.

Key Takeaways

Multiple sclerosis is a progressive, demyelinating disease on the central nervous system, characterized by the destruction of myelin, the protective sheath surrounding nerve cells, as well as inflammation and scarring of nerve fibers.

Damage to these nerves disrupts the ability of parts of the nervous system to transmit impulses, resulting in a wide range of signs and symptoms, including physical, mental, and sometimes psychiatric problems. Symptoms vary widely, but they may include muscle weakness, fatigue, vision problems, balance and coordination problems, and problems with memory and thinking.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine" McGraw Hill Education/ Medical (2018)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  4. "CURRENT Medical Diagnosis and Treatment 2020" McGraw Hill Professional (2019)
  5. "Multiple sclerosis" The Lancet (2008)
  6. "Defining the clinical course of multiple sclerosis: Results of an international survey" Neurology (1996)